Troikaa Pharmaceuticals Limited — Heparin Exporter Profile
Indian Pharmaceutical Exporter · #7 for Heparin · $3.6M export value · DGFT Verified
Troikaa Pharmaceuticals Limited is the #7 Indian exporter of Heparin with $3.6M in export value and 72 verified shipments. Troikaa Pharmaceuticals Limited holds a 1.0% market share in Heparin exports across 8 countries. The company exports 13 pharmaceutical products worth $40.4M across 6 therapeutic categories.
Troikaa Pharmaceuticals Limited — Heparin Export Profile: Buyers & Destinations
Where Does Troikaa Pharmaceuticals Limited Export Heparin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $1.6M | 49 | 66.8% |
| THAILAND | $358.3K | 9 | 15.3% |
| FRANCE | $104.1K | 3 | 4.4% |
| DOMINICAN REPUBLIC | $67.2K | 2 | 2.9% |
| DOMINICAN REPULIC | $50.0K | 1 | 2.1% |
| YEMEN | $49.6K | 1 | 2.1% |
| ECUADOR | $44.3K | 2 | 1.9% |
| TRINIDAD & TOBAGO | $38.6K | 2 | 1.6% |
| GUYANA | $37.8K | 2 | 1.6% |
| TRINIDAD AND TOBAGO | $29.2K | 2 | 1.2% |
Troikaa Pharmaceuticals Limited exports Heparin to 10 countries. The largest destination is PHILIPPINES accounting for 66.8% of Troikaa Pharmaceuticals Limited's Heparin shipments, followed by THAILAND (15.3%) and FRANCE (4.4%). These destinations reflect Troikaa Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Heparin from Troikaa Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TROIKAA PHARMACEUTICALS PHILIPPINES | PHILIPPINES | $797.3K | 28 |
| T . P . P . I | PHILIPPINES | $457.0K | 11 |
| P . P . L . P | THAILAND | $150.0K | 3 |
| SEAN DOMINICAN SRL | DOMINICAN REPULIC | $117.2K | 3 |
| PINYO PHARMACY LTD., PART. | THAILAND | $108.3K | 4 |
| P.P | FRANCE | $104.1K | 3 |
| TROIKAA PHARMACEUTICALS PHILIPPINE | PHILIPPINES | $96.8K | 2 |
| T P P I | PHILIPPINES | $73.5K | 2 |
| TROIKA PHARMACEUTICALS PHILIPPINES | PHILIPPINES | $72.4K | 2 |
| SUPERIOR PHARMA LIMITED | TRINIDAD & TOBAGO | $65.2K | 3 |
Troikaa Pharmaceuticals Limited supplies Heparin to 19 buyers globally. The largest buyer is TROIKAA PHARMACEUTICALS PHILIPPINES (PHILIPPINES), followed by T . P . P . I (PHILIPPINES) and P . P . L . P (THAILAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Heparin Export Value and How Much Does Troikaa Pharmaceuticals Limited Contribute?
India exported $112.6M worth of Heparin through 4,586 shipments from 391 suppliers to 137 countries, serving 854 buyers globally. Troikaa Pharmaceuticals Limited contributes $3.6M to this total, accounting for 1.0% of India's Heparin exports. Troikaa Pharmaceuticals Limited ships Heparin to 10 countries through 19 buyers.
What Is the Average Shipment Value for Troikaa Pharmaceuticals Limited's Heparin Exports?
Troikaa Pharmaceuticals Limited's average Heparin shipment value is $50.0K per consignment, based on 72 shipments totaling $3.6M. The largest destination is PHILIPPINES (66.8% of Troikaa Pharmaceuticals Limited's Heparin exports).
How Does Troikaa Pharmaceuticals Limited Compare to Other Indian Heparin Exporters?
Troikaa Pharmaceuticals Limited ranks #7 among 391 Indian Heparin exporters with a 1.0% market share. The top 3 exporters are GLAND PHARMA LTD ($45.3M), GLAND PHARMA LIMITED ($38.1M), ACULIFE HEALTHCARE PRIVATE LIMITED ($4.4M). Troikaa Pharmaceuticals Limited processed 72 shipments to 8 destination countries.
What Heparin Formulations Does Troikaa Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICALS FORMULATIONS- Heparin So | $360.9K | 11 |
| PHARMACEUTICALS FORMULATIONS- Heparin Sodium Injection BP 5000IU/ML-5ML Vial (25000 IU in 5ML) Nuparin | $100.0K | 2 |
| PHARMACEUTICALS FORMULATIONS: Heparin Sodium Injection BP 5000IU/ML-5ML-5ML Vial(25000IU in 5ML) (Nuparin)(QTY: 35000 V | $100.0K | 2 |
| HEPARIN SODIUM INJECTION BP 5000IU/ML-5M | $87.9K | 3 |
| PHARMACEUTICALS FORMULATIONS: HEMOLATE HEPARIN INJECTION BP (QTY: 50,215.00 BOX) | $86.3K | 2 |
| PHARMACEUTICALS FORMULATIONS: NUPARIN HEPARIN INJECTION BP (QTY: 49,975 BOX) | $68.1K | 2 |
| PHARMACEUTICALS FORMULATIONS: Heparin Sodium Injection BP 5000IU/ML-5ML-5ML Vial(25000IU in 5ML) (Nuparin)(QTY: 15150 V | $66.5K | 2 |
| HEPARIN SODIUM INJECTION BP 5000IU/ML- 5ML- 5ML VIAL (25000IU IN 5ML) NUPARIN | $60.2K | 3 |
| PHARMACEUTICALS FORMULATIONS- HEPARIN SODIUM INJECTION BP 5000IU/ML-5ML VIAL (25000 IU IN 5ML) NUPARINVLS | $59.7K | 3 |
| PHARMACEUTICALS FORMULATIONS - Heparin S | $54.1K | 2 |
Troikaa Pharmaceuticals Limited exports 45 distinct Heparin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICALS FORMULATIONS- Heparin So with 11 shipments worth $360.9K.
How Does Troikaa Pharmaceuticals Limited Compare to Nearest Heparin Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | EMCURE PHARMACEUTICALS LIMITED | $3.9M | 181 | 15 | $21.4K |
| 3 | CAPLIN POINT LABORATORIES LIMITED | $3.7M | 74 | 4 | $50.0K |
| 7 | TROIKAA PHARMACEUTICALS LIMITED ★ | $3.6M | 72 | 8 | $50.0K |
| 5 | MYLAN LABORATORIES LIMITED | $3.3M | 66 | 1 | $50.0K |
| 14 | SCOTT EDIL PHARMACIA LIMITED | $1.7M | 53 | 10 | $32.8K |
Troikaa Pharmaceuticals Limited ranks #7 among 391 Indian Heparin exporters. Average shipment value of $50.0K compared to the market average of $288.0K. The closest competitors by value are EMCURE PHARMACEUTICALS LIMITED and CAPLIN POINT LABORATORIES LIMITED.
Which Indian Ports Ship Heparin Exports?
| Port | Shipments | % Share |
|---|---|---|
| HYDERABAD ICD | 669 | 14.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 507 | 11.1% |
| HYDERABAD ICD (INSNF6) | 486 | 10.6% |
| SAHAR AIR | 441 | 9.6% |
| DELHI AIR CARGO ACC (INDEL4) | 221 | 4.8% |
| NHAVA SHEVA SEA (INNSA1) | 213 | 4.6% |
| Bombay Air | 156 | 3.4% |
| HYDERABAD AIR | 153 | 3.3% |
What Other Cardiovascular Products Does Troikaa Pharmaceuticals Limited Export?
Troikaa Pharmaceuticals Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Troikaa Pharmaceuticals Limited's Heparin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Troikaa. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight costs and extended transit times. These logistical challenges are particularly impactful for time-sensitive pharmaceutical shipments, potentially affecting Troikaa's supply chain efficiency. (pharmaceuticalcommerce.com)
In the United States, recent tariff implementations have introduced uncertainties for Indian exporters. While initial tariffs targeted various sectors, the pharmaceutical industry has faced threats of increased duties, prompting companies to reassess their export strategies. (apnews.com) Conversely, the India–EFTA Trade and Economic Partnership Agreement, effective from October 2025, aims to reduce tariffs and promote trade between India and EFTA countries, potentially opening new avenues for Troikaa in European markets. (en.wikipedia.org)
Troikaa Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical factor for Indian pharmaceutical exporters. The U.S. FDA has intensified inspections, with over 200 conducted in 2023 and plans to increase this number in 2024. (fact.net.in) This heightened scrutiny underscores the necessity for companies like Troikaa to maintain stringent quality control measures to ensure uninterrupted market access.
Additionally, the European Union's Falsified Medicines Directive imposes rigorous requirements on pharmaceutical imports, necessitating robust traceability and authentication systems. Adherence to these evolving regulations is imperative for sustaining Troikaa's export operations in these regions.
About Troikaa Pharmaceuticals Limited
Troikaa Pharmaceuticals Limited exports 13 products worth $40.4M. Beyond Heparin, top products include Diclofenac, Sodium, Enoxaparin, Amiodarone, Nitroglycerin. View the complete Troikaa Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Heparin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Heparin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Troikaa Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 73 individual customs records matching Troikaa Pharmaceuticals Limited exporting Heparin, covering 45 formulations to 10 countries via 19 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 137+ countries, 854+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Heparin Export Data from Troikaa Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Troikaa Pharmaceuticals Limited's Heparin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Troikaa Pharmaceuticals Limited
Full Company Profile →
13 products · $40.4M total trade · 6 categories
Heparin Stats
Company Overview
Top Products by Troikaa Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Troikaa Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Heparin. For current shipment-level data, contact TransData Nexus.